300452.SZ
山河药辅
SZSE · Healthcare · C 制造业 · CN
CNY 12.58
−1.49%Margins
Gross margin
31.7%
EBITDA margin
26.5%
EBIT margin
21.0%
Net margin
18.4%
FCF margin
17.7%
16.7%
Return on equity
10.0%
Return on assets
18.7%
Return on invested capital
0.55x
Asset turnover
CNY 212.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026